Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-03-14 Sale(A) | 2022-03-15 7:12 pm | Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer | 63,340 | $0.31 | $19,635 | 65,292 (Direct) | View |
| 2022-03-14 Sale | 2022-03-15 5:01 pm | Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer | 47,132 | $0.38 | $17,910 | 181,500 (Direct) | View |
| 2021-01-26 Sale | 2021-01-27 7:32 pm | Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer | 33,868 | $1.73 | $58,592 | 28,632 (Direct) | View |
| 2020-09-30 Sale | 2020-10-02 9:00 pm | Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer | 56,130 | $1.64 | $92,053 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-31 Option Award | 2023-04-03 8:00 pm | N/A 2033-03-30 | Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-03-11 Tax Withholding | 2023-03-14 6:00 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer | 2,883 | $0.96 | 8,135 (Direct) | View |
| 2023-03-11 Exercise | 2023-03-14 6:00 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer | 6,666 | $0 | 8,135 (Direct) | View |
| 2023-03-11 Option Award | 2023-03-14 6:00 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer | 6,666 | $0 | 8,135 (Direct) | View |
| 2022-03-11 Exercise | 2022-03-15 5:01 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer | 100,000 | $0 | 181,500 (Direct) | View |
| 2022-03-11 Option Award | 2022-03-15 5:01 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer | 100,000 | $0 | 181,500 (Direct) | View |
| 2021-06-23 Option Award | 2021-06-25 4:05 pm | N/A 2031-06-22 | Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer | 1,936,000 | $0 | 1,936,000 (Direct) | View |
| 2021-03-11 Option Award | 2021-03-15 4:30 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer | 200,000 | $0 | 200,000 (Direct) | View |
| 2021-01-25 Option Award | 2021-01-27 7:32 pm | N/A N/A | Iterum Therapeutics plc | ITRM | Matthews Judith M. Chief Financial Officer | 62,500 | $0 | 28,632 (Direct) | View |